The acquisition, which involved the issuance of consideration shares under a special mandate to purchase 100% of the issued shares of Shanghai Siyanli Industrial, has now been finalized. All conditions precedent set forth in the share purchase agreement have been satisfied, with the transaction officially closing on January 7, 2026, in accordance with the agreement's terms and conditions. Following the completion of the acquisition and as of the date of this announcement, the target company has become an indirectly wholly-owned subsidiary of BEAUTYFARM MED. Its operational results and financial position will now be consolidated into the Group's comprehensive financial statements.
Comments